Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamidoamine dendrimer
Journal of Bioscience and Bioengineering, ISSN: 1389-1723, Vol: 95, Issue: 5, Page: 541-543
2003
- 73Citations
- 10Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations73
- Citation Indexes73
- CrossRef73
- Captures10
- Readers10
- 10
Article Description
In search of an efficient transdermal drug delivery system (TDDS), a polyhydroxyalkanoate (PHA)-based system with a polyamidoamine dendrimer was examined. Tamsulosin was used as the model drug. The dendrimer was found to act as the weak enhancer. By adding the dendrimer, the dendrimer-containing PHA matrix achieved the clinically required amount of tamsulosin permeating through the skin model. This is also the first report of the application of PHA and dendrimer to the TDDS.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1389172303800592; http://dx.doi.org/10.1016/s1389-1723(03)80059-2; http://www.ncbi.nlm.nih.gov/pubmed/16233454; http://linkinghub.elsevier.com/retrieve/pii/S1389172303800592; http://api.elsevier.com/content/article/PII:S1389172303800592?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1389172303800592?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S1389172303800592; http://dx.doi.org/10.1016/s1389-1723%2803%2980059-2; https://dx.doi.org/10.1016/s1389-1723%2803%2980059-2
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know